http://credence.org/news/news.htm
"TRADE SECRETS": THE LATEST IN A
LONG LINE OF CONSPIRACIES CHARGES
Press release
SAMUEL S. EPSTEIN, M.D.
Bill Moyers is to be warmly
commended for his March 26 program "Trade Secrets". This PBS
Special will document the chemical industry's conspiracy in denying information
on the grave cancer risks to hundreds of thousands of workers manufacturing the
potent carcinogen vinyl chloride (VC) and its polyvinyl chloride (PVC)
product.
As newsworthy is the fact
that there is a decades-long track record of numerous such conspiracies
involving a wide range of industries and chemicals, besides VC. These
conspiracies have resulted in an escalation in the incidence and mortality of
cancer, and chronic disease, among workers and the general public unknowingly
exposed to toxics and carcinogens in the workplace, air, water and consumer
products--food, household products, and cosmetics and toiletries.
This misconduct involves
negligence, manipulation, suppression, distortion and destruction of health and
environmental data by mainstream industries, their consultants and trade
associations, notably the Chemical Manufacturers Association (CMA). These
practices are so frequent as to preclude dismissal as exceptional aberrations
and, in many instances, arguably rise to the level of criminality as
illustrated below:
· Suppression of evidence
from the early 1960's on the toxicity of VC by Dow Chemical, and on its
carcinogenicity from 1970 by the VC/PVC industry and the CMA. Based on these
findings, a blue ribbon committee of the American Association for the
Advancement of Science charged in 1976 that: "Because of the
suppression of these data (by the CMA), tens of thousands of workers were
exposed without warning--to toxic concentrations of VC".
· Suppression of evidence
since the 1930's on the hazards of asbestos, asbestosis and lung cancer, by
Johns-Manville and Raybestos-Manhattan, besides the Metropolitan Life Insurance
Company. This information was detailed in industry documents dubbed the
"Asbestos Pentagon Papers", released at 1978 Congressional Hearings.
· Suppression by Rohm and
Haas of information, known since 1962 but not released until 1971, on the
potent carcinogenicity of the resin bischloromethylether. This resulted in
deaths from lung cancer of some 50 men, many non-smokers and under the age of
50.
· Suppression of
carcinogenicity data on organochlorine pesticides: Aldrin/Dieldrin, by
Shell Chemical Company since 1962; Chlordane/Heptachlor, by Velsicol Chemical
Company since 1959; and Kepone, by Allied Chemical Company since the early
1960's.
· Falsification in the
early 1970's of test data on the drug Aldactone and artificial sweetener
Aspartame by Hazleton Laboratories under contract to G.D. Searle Company.
· Falsification and manipulation
by Monsanto since the 1960's of data on dioxin, and its contamination of
products including the herbicide Agent Orange, designed to block occupational
exposure claims and tightening of federal regulations. This evidence was
detailed in 1990 by Environmental Protection Agency's Office of Criminal
Investigation which charged Monsanto with a "long pattern of fraud"
and with reporting "false information" to the Agency.
· Fraudulent claims by
Monsanto since 1985 that genetically engineered (rBGH) milk is
indistinguishable from natural milk. These claims persist despite
contrary evidence.
· Monsanto's reckless
marketing in 1976 of plastic Coke bottles made from acrylonitrile, a chemical
closely related to VC, prior to its testing for carcinogenicity and migration
into the Coke. The bottles were subsequently banned after acrylonitrile
was found to be a potent carcinogen contaminating the Coke.
· Destruction of
epidemiological data on ethyleneimine and other chemicals by Dow and
DuPont. This was admitted at 1973 Department of Labor Advisory Committee
meetings in response to challenges to produce data on whose basis industry had
falsely claimed that these chemicals were not carcinogens.
· Destruction of test data
on drugs, food additives, and pesticides as admitted in 1977 by Industrial
Biotest Laboratories, under contract to major chemical industries.
· Failure of the mainstream
cosmetics and toiletry industries to warn of the wide range of avoidable carcinogenic
ingredients, contaminants and precursors in their products used by the great
majority of the U.S. population over virtually their lifetimes.
(For supporting
documentation of the above charges, see the author's: Testimony on White
Collar Crime, H.R. 4973, before the Subcommittee on Crime of the House
Judiciary Committee, 12/13/79; The Politics of Cancer, 1979; and The Politics
of Cancer, Revisited, 1998.)
Hopefully, the public and
the media will be outraged by this longstanding evidence of recklessness and
conspiracies, graphically reinforced by Moyers' program. The public and the
media should finally hold industry accountable, and demand urgent investigation
and radical reform of current industry practices besides governmental
unresponsiveness. The Moyers' program has already galvanized formation of
a coalition of grassroots citizen groups, "Coming Clean", to demand
more responsible and open industry practices, including phasing out the use and
manufacture of toxic chemicals.
Criticism should also be
directed to the multibillion dollar cancer establishment--the National Cancer
Institute and American Cancer Society--for their failure to warn Congress,
regulatory agencies and the general public of the scientific evidence on the
permeation of the totality of the environment with often persistent industrial
carcinogens thus precluding corrective legislation and regulation, besides
denying workers and the public of their inalienable right-to-know.
NOTE: PRNewswire, the
nation's largest newswire service, who has released Cancer Prevention
Coalition's numerous press releases for the last five years, refused to issue
this release on "legal grounds".
DATE March 23, 2001
SOURCE Cancer Prevention
Coalition
CONTACT: Samuel S. Epstein, M.D.,
Chairman of the Cancer Prevention Coalition and Professor environmental and
occupational medicine, University of Illinois School of Public Health, Chicago,
312-996-2297;epstein@uic.edu; http://www.preventcancer.com